◆英語タイトル：Neoleukin Therapeutics Inc (NLTX) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Neoleukin Therapeutics Inc (Neoleukin), formely Aquinox Pharmaceuticals Inc is a biopharmaceutical company develops next generation immunotherapies to treat immunological disorders. The company’s lead drug candidate NL-201 is a combined IL-2 and IL-15 protein therapeutic used as an agonist in the treatment of cancer immunotherapy. Its propriety platform de novo – proteins enables to build custom protein therapeutics. Neoleukin serves in the therapeutic areas of rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, asthma, atopic dermatitis and solid tumors. The company seeks to collaborate with academic institutions, and pharmaceutical companies for developing its technology platform. Neoleukin is headquartered in Seattle, Washington, the US.
Neoleukin Therapeutics Inc Key Recent Developments
Mar 25,2021: Neoleukin Therapeutics Announces Year End 2020 Financial Results
Mar 18,2021: Neoleukin Therapeutics to Host 2020 Financial Results Conference Call and Webcast on March 25, 2021
Mar 02,2021: Neoleukin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
Jan 07,2021: Neoleukin Therapeutics to Present at J.P. Morgan Healthcare Conference
This comprehensive SWOT profile of Neoleukin Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Neoleukin Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Neoleukin Therapeutics Inc – Key Information
Neoleukin Therapeutics Inc – Overview
Neoleukin Therapeutics Inc – Key Employees
Neoleukin Therapeutics Inc – Key Employee Biographies
Neoleukin Therapeutics Inc – Key Operational Heads
Neoleukin Therapeutics Inc – Major Products and Services
Neoleukin Therapeutics Inc – History
Neoleukin Therapeutics Inc – Company Statement
Neoleukin Therapeutics Inc – Locations And Subsidiaries
Neoleukin Therapeutics Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Neoleukin Therapeutics Inc – Business Description
Neoleukin Therapeutics Inc – Corporate Strategy
Neoleukin Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Neoleukin Therapeutics Inc – Strengths
Neoleukin Therapeutics Inc – Weaknesses
Neoleukin Therapeutics Inc – Opportunities
Neoleukin Therapeutics Inc – Threats
Neoleukin Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Neoleukin Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Neoleukin Therapeutics Inc, Key Information
Neoleukin Therapeutics Inc, Key Ratios
Neoleukin Therapeutics Inc, Share Data
Neoleukin Therapeutics Inc, Major Products and Services
Neoleukin Therapeutics Inc, History
Neoleukin Therapeutics Inc, Key Employees
Neoleukin Therapeutics Inc, Key Employee Biographies
Neoleukin Therapeutics Inc, Key Operational Heads
Neoleukin Therapeutics Inc, Other Locations
Neoleukin Therapeutics Inc, Subsidiaries
Neoleukin Therapeutics Inc, Key Competitors
Neoleukin Therapeutics Inc, SWOT Analysis
Neoleukin Therapeutics Inc, Ratios based on current share price
Neoleukin Therapeutics Inc, Annual Ratios
Neoleukin Therapeutics Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Neoleukin Therapeutics Inc (NLTX)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら